Vively just raised. Here's exactly what to do next.
Who to reach, what to say, and why now — on Vively, plus every funding round, exec hire, and M&A move that follows. Verified, ICP-ranked contacts on demand (email + mobile).
Used by professionals at BlackRock, Oracle, Kleiner Perkins, HubSpot, and other leading firms — built on 10 years of proprietary signal data.
Everyone else gives you a piece
Only Fundz delivers all four.
Vively has raised $1.6 million in seed funding, led by Archangel Ventures, to bring continuous glucose monitors and dietician coaching to the masses.
Amount Raised
$1.6 Million
Round Type
seed
Investors
Description
Vively has raised $1.6 million in seed funding, led by Archangel Ventures with participation from Bupa Ventures and others. The funds will help reduce the cost of continuous glucose monitors (CGMs) linked to their app to $99. Prior to this, CGMs were only accessible through a doctor's prescription. The company's mission is to tackle diabetes prevention with its innovative health solutions.
Related People
Funding Insights
Based on industry dataWatching Vively? See every signal — funding, hires, M&A, contracts, sentiment.
Request a demoChoose your plan